ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
5.00
+0.21 (4.38%)
At close: Apr 1, 2025, 4:00 PM
5.10
+0.10 (2.00%)
After-hours: Apr 1, 2025, 4:35 PM EDT
ImmuCell Revenue
In the year 2024, ImmuCell had annual revenue of $26.49M with 51.63% growth. ImmuCell had revenue of $7.75M in the quarter ending December 31, 2024, with 52.10% growth.
Revenue (ttm)
$26.49M
Revenue Growth
+51.63%
P/S Ratio
1.48
Revenue / Employee
$335,354
Employees
79
Market Cap
44.56M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 26.49M | 9.02M | 51.63% |
Dec 31, 2023 | 17.47M | -1.10M | -5.90% |
Dec 31, 2022 | 18.57M | -675.01K | -3.51% |
Dec 31, 2021 | 19.24M | 3.90M | 25.43% |
Dec 31, 2020 | 15.34M | 1.62M | 11.80% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ICCC News
- 4 weeks ago - ImmuCell Corporation (ICCC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024 - GlobeNewsWire
- 5 weeks ago - ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024 - GlobeNewsWire
- 2 months ago - ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses - GlobeNewsWire
- 2 months ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024 - GlobeNewsWire
- 4 months ago - ImmuCell Corporation (ICCC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024 - GlobeNewsWire
- 5 months ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 - GlobeNewsWire